Highlights
A collection of news and information related to Lantus (drug) published by this site and its partners.
Displaying items 1-4 of 4
» View wsbt.com items only
-
Novo Nordisk shares hit by concerns over rival diabetes drugs
ReutersCOPENHAGEN (Reuters) - Novo Nordisk , the world's biggest insulin producer, faces more competition in the diabetes field from rivals Eli Lilly and Sanofi , both of which will showcase new products at an upcoming medical meeting. Shares in the Danish...Tags: Lilly Eli & Co, American Diabetes Association, Drugs and Medicines, Medical Procedures and Tests, Diabetes
-
Sanofi avanza en el mercado de la diabetes ante dura competencia
ReutersPor Elena Berton FRANCFORT (Reuters) - En una barrio residencial de Fráncfort, Alemania, una planta de última generación produce diariamente hasta 1 millón de bolígrafos de insulina en el marco de una iniciativa de la farmacéutica francesa Sanofi...Tags: Lilly Eli & Co, Bristol Myers Squibb Company, AstraZeneca Plc, Diabetes
-
Sanofi steps up diabetes drive as rivals raise the stakes
Reuters* French drugmaker banking on improved version of Lantus * Investing in smart technology to bolster diabetes business * Novo Nordisk setback an opportunity in competitive market * Key data on new Sanofi products at ADA meeting this month By Elena...Tags: Marketing, Bristol Myers Squibb Company, American Diabetes Association, New Products, Drugs and Medicines
-
EU backs Celgene, Aegerion drugs; sees no Lantus cancer risk
ReutersLONDON, May 31 (Reuters) - European regulators have recommended approval of a new drug from Celgene for patients with multiple myeloma whose disease has worsened after being treated with other cancer drugs. Friday's green light from the European...Tags: Celgene Corporation, Drugs and Medicines
Jun 17, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
Jun 7, 2013
|Story| Reuters
May 31, 2013
|Story| Reuters
Original site for Lantus (drug) topic gallery.